Stefanie Stanzer is a senior scientist and cancer expert at CBmed, where she has been a key contributor since 2020. She is the deputy head of the compound screening technology program and coordinates both the scientific research and the team. In addition to her expertise in these areas, she is highly skilled in application for ethical approvals for clinical studies.

She earned her PhD in tumor immunology from the Medical University of Graz. She is passionate about developing innovative project ideas in cancer research and applied technologies, and thrives in an interdisciplinary, dynamic team environment. Outside of her professional work, she enjoys cross-country mountain biking, skiing, and ski touring.